Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation

Endocrinology

Volumn 148, Issue 1, 2007, Pages 148-159

  Chung, Hyunju ^a   Kim, Eunhee ^a   Dae, Hee Lee ^b   Seo, Sanghee ^a   Ju, Sunghee ^a   Lee, Dahm ^a   Kim, Hocheol ^b   Park, Seungjoon ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME C; GHRELIN; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; HYPOTHALAMUS; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NERVE CELL; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN ISCHEMIA; CASPASE 3; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOCHROMES C; DISEASE MODELS, ANIMAL; GLUCOSE; HYPOTHALAMUS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; OXYGEN; PEPTIDE HORMONES; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER;

EID: 33845910446     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0991     Document Type: Article

References (83)

1. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M 2000 Ghrelin, a novel growth hormone-relasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255-4261
2. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth hormone-relesasing acylated peptide from stomach. Nature 402:656-660
3. Peino R, Baldelli R, Rodriguez-Garcia J, Rodriguez-Segade S, Kojima M, Kangawa K, Arvat E, Ghigo E, Dieguez C, Casanueva FF 2000 Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol 143:R11-R14
4. Tschop M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
5. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198
6. Kojima M, Kangawa K 2005 Ghrelin: structure and function. Physiol Rev 85:495-522
7. Van der Lely AJ, Tschop M, Heiman ML, Ghigo E 2004 Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457
8. Ghigo E, Broglio F, Arvat E, Maccario M, Papotti M, Muccioli G 2005 Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) 62:1-17
9. Mattson MP, Culmsee C, Yu ZF 2000 Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 301:173-187
10. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A 2002 Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159:1029-1037
11. Kim MS, Yoon CY, Jang PG, Park YJ, Shin CS, Park HS, Ryu JW, Pak YK, Park JY, Lee KU, Kim SY, Lee HK, Kim YB, Park KS 2004 The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 18:2291-2301
12. Nanzer AM, Khalaf S, Mozid AM, Fowkes RC, Patel MV, Burrin JM, Grossman AB, Korbonits M 2004 Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur J Endocrinol 151:233-240
13. Kim SW, Her SJ, Park SJ, Kim D, Park KS, Lee HK, Han BH, Kim MS, Shin CS, Kim SY 2005 Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 37:359-369
14. Frago LM, Paneda C, Dickson SL, Hewson AK, Argente J, Chowen JA 2002 Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 143:4113-4122
15. Diano S, Farr SA, Benoit SC, McNay EC, da S, I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschop MH, Horvath TL 2006 Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9:381-388
16. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD 1997 Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48:23-29
17. Mitchell V, Bouret S, Beauvillain JC, Schilling A, Perret M, Kordon C, Epelbaum J 2001 Comparative distribution of mRNA encoding the growth hormone secretagogue-receptor (GHS-R) in Microcebus murinus (Primate, lemurian) and rat forebrain and pituitary. J Comp Neurol 429:469-489
18. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL 2003 The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661
19. Chan PH 2004 Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem Res 29:1943-1949
20. Igaz P, Salvi R, Rey JP, Glauser M, Pralong FP, Gaillard RC 2006 Effects of cytokines on gonadotropin-releasing hormone (GnRH) gene expression in primary hypothalamic neurons and in GnRH neurons immortalized conditionally. Endocrinology 147:1037-1043
21. Tabakman R, Jiang H, Levine RA, Kohen R, Lazarovici P 2004 Apoptotic characteristics of cell death and the neuroprotective effect of homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J Neurosci Res 75:499-507
22. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH 1996 The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 271:31929-31936
23. Park S, Sohn S, Kineman RD 2004 Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. J Endocrinol 180:369-378
24. Jiang X, Mu D, Manabat C, Koshy AA, Christen S, Tauber MG, Vexler ZS, Ferriero DM 2004 Differential vulnerability of immature murine neurons to oxygen-glucose deprivation. Exp Neurol 190:224-232
25. Nagasawa H, Kogure K 1989 Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 20:1037-1043
26. Brzozowski T, Konturek PC, Drozdowicz D, Konturek SJ, Pawlik M, Sliwowski Z, Pawlik WW, Hahn EG 2005 Role of central and peripheral ghrelin in the mechanism of gastric mucosal defence. Inflammopharmacology 13:45-62
27. Brzozowski T, Konturek PC, Konturek SJ, Kwiecien S, Drozdowicz D, Bielanski W, Pajdo R, Ptak A, Nikiforuk A, Pawlik WW, Hahn EG 2004 Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept 120:39-51
28. Li F, Irie K, Anwer MS, Fisher M 1997 Delayed triphenyltetrazolium chloride staining remains useful for evaluating cerebral infarct volume in a rat stroke model. J Cereb Blood Flow Metab 17:1132-1135
29. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K, Grossman AB 2001 The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 86:881-887
30. Malagelada C, Xifro X, Minano A, Sabria J, Rodriguez-Alvarez J 2005 Contribution of caspase-mediated apoptosis to the cell death caused by oxygen-glucose deprivation in cortical cell cultures. Neurobiol Dis 20:27-37
31. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A 2002 Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22:10291-10301
32. Yoshida E, Atkinson TG, Chakravarthy B 2004 Neuroprotective gene expression profiles in ischemic cortical cultures preconditioned with IGF-1 or bFGF. Brain Res Mol Brain Res 131:33-50
33. Smith RG, Cheng K, Schoen WR, Pong SS, Hickey G, Jacks T, Butler B, Chan WW, Chaung LY, Judith F 1993 A nonpeptidyl growth hormone secretagogue. Science 260:1640-1643
34. Kyriakis JM, Avruch J 2001 Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869
35. Takman R, Jiang H, Schaefer E, Levine RA, Lazarovici P 2004 Nerve growth factor pretreatment attenuates oxygen and glucose deprivation-induced c-Jun amino-terminal kinase 1 and stress-activated kinases p38α and p38β activation and confers neuroprotection in the pheochromocytoma PC12 Model. J Mol Neurosci 22:237-250
36. Shen CC, Huang HM, Ou HC, Chen HL, Chen WC, Jeng KC 2004 Protective effect of nicotinamide on neuronal cells under oxygen and glucose deprivation and hypoxia/reoxygenation. J Biomed Sci 11:472-481
37. MacGregor DG, Avshalumov MV, Rice ME 2003 Brain edema induced by in vitro ischemia: causal factors and neuroprotection. J Neurochem 85:1402-1411
38. Tabakman R, Lazarovici P, Kohen R 2002 Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J Neurosci Res 68:463-469
39. Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, McCormick ML, Sigmund CD, Tang C, Weintraub NL 2004 Ghrelin inhibits proinflammatory responses and nuclear factor-κB activation in human endothelial cells. Circulation 109:2221-2226
40. Iseri SO, Sener G, Yuksel M, Contuk G, Cetinel S, Gedik N, Yegen BC 2005 Ghrelin against alendronate-induced gastric damage in rats. J Endocrinol 187:399-406
41. Green DR, Reed JC 1998 Mitochondria and apoptosis. Science 281:1309-1312
42. Ly JD, Grubb DR, Lawen A 2003 The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 8:115-128
43. Leinninger GM, Russell JW, van Golen CM, Berent A, Feldman EL 2004 Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma. Cell Death Differ 11:885-896
44. Toescu EC, Verkhratsky A 2000 Assessment of mitochondrial polarization status in living cells based on analysis of the spatial heterogeneity of rhodamine 123 fluorescence staining. Pflugers Arch 440:941-947
45. Legrand O, Perrot JY, Simonin G, Baudard M, Marie JP 2001 JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia. Blood 97:502-508
46. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G 1996 Mitochondrial control of nuclear apoptosis. J Exp Med 183:1533-1544
47. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, Tsujimoto Y 1998 Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 95:14681-14686
48. Kang BP, Urbonas A, Baddoo A, Baskin S, Malhotra A, Meggs LG 2003 IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose. Am J Physiol Renal Physiol 285:F1013-F1024
49. Leri A, Liu Y, Claudio PP, Kajstura J, Wang X, Wang S, Kang P, Malhotra A, Anversa P 1999 Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretchmediated apoptosis. Am J Pathol 154:567-580
50. Banasiak KJ, Xia Y, Haddad GG 2000 Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol 62:215-249
51. Merry DE, Korsmeyer SJ 1997 Bcl-2 gene family in the nervous system. Annu Rev Neurosci 20:245-267
52. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S 2002 Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240-244
53. Chang L, Ren Y, Liu X, Li WG, Yang J, Geng B, Weintraub NL, Tang C 2004 Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol 43:165-170
54. Konturek PC, Brzozowski T, Walter B, Burnat G, Hess T, Hahn EG, Konturek SJ 2006 Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. Eur J Pharmacol 536:171-181
55. Bresciani E, Nass R, Torsello A, Gaylinn B, Avallone R, Locatelli V, Thorner MO, Muller EE 2004 Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites. Neuroendocrinology 80:52-59
56. Pang JJ, Xu RK, Xu XB, Cao JM, Ni C, Zhu WL, Asotra K, Chen MC, Chen C 2004 Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro. Am J Physiol Heart Circ Physiol 286:H1063-H1069
57. Jiang Z, Zhang Y, Chen X, Lam PY, Yang H, Xu Q, Yu AC 2002 Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochem Biophys Res Commun 294:726-733
58. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong S-S, Chaung L-Y, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LHT 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
59. Kohno D, Gao HZ, Muroya S, Kikuyama S, Yada T 2003 Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52:948-956
60. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K, Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183
61. Maroney AC, Finn JP, Bozyczko-Coyne D, O'Kane TM, Neff NT, Tolkovsky AM, Park DS, Yan CY, Troy CM, Greene LA 1999 CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J Neurochem 73:1901-1912
62. Heidenreich KA, Kummer JL 1996 Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J Biol Chem 271:9891-9894
63. Creedon DJ, Johnson EM, Lawrence JC 1996 Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J Biol Chem 271:20713-20718
64. Virdee K, Tolkovsky AM 1996 Inhibition of p42 and p44 mitogen-activated protein kinase activity by PD98059 does not suppress nerve growth factor-induced survival of sympathetic neurones. J Neurochem 67:1801-1805
65. Fleury C, Mignotte B, Vayssiere JL 2002 Mitochondrial reactive oxygen species in cell death signaling. Biochimie (Paris) 84:131-141
66. Sidoti-de FC, Rincheval V, Risler Y, Mignotte B, Vayssiere JL 1998 TNF-α activates at least two apoptotic signaling cascades. Oncogene 17:1639-1651
67. Ellerby LM, Ellerby HM, Park SM, Holleran AL, Murphy AN, Fiskum G, Kane DJ, Testa MP, Kayalar C, Bredesen DE 1996 Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J Neurochem 67:1259-1267
68. Yuan J, Yankner BA 2000 Apoptosis in the nervous system. Nature 407:802-809
69. Shi Y 2001 A structural view of mitochondria-mediated apoptosis. Nat Struct Biol 8:394-401
70. Korsmeyer SJ 1995 Regulators of cell death. Trends Genet 11:101-105
71. Fujimura M, Morita-Fujimura Y, Murakami K, Kawase M, Chan PH 1998 Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 18:1239-1247
72. Perez-Pinzon MA, Xu GP, Born J, Lorenzo J, Busto R, Rosenthal M, Sick TJ 1999 Cytochrome c is released from mitochondria into the cytosol after cerebral anoxia or ischemia. J Cereb Blood Flow Metab 19:39-43
73. Hirai K, Sugawara T, Chan PH, Basus VJ, James TL, Litt L 2002 Cytochrome c associated apoptosis during ATP recovery after hypoxia in neonatal rat cerebrocortical slices. J Neurochem 83:309-319
74. Sugawara T, Fujimura M, Morita-Fujimura Y, Kawase M, Chan PH 1999 Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J Neurosci 19:RC39
75. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P, Flavell RA 1998 Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94:325-337
76. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X 1997 Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489
77. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM, Mak TW 1998 Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94:739-750
78. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X 1997 Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413
79. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ 1999 Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144:281-292
80. Fisher M, Meadows ME, Do T, Weise J, Trubetskoy V, Charette M, Finklestein SP 1995 Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 15:953-959
81. Shigeno T, Mima T, Takakura K, Graham DI, Kato G, Hashimoto Y, Furukawa S 1991 Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J Neurosci 11:2914-2919
82. Miyazaki H, Okuma Y, Fujii Y, Nagashima K, Nomura Y 1999 Glial cell line-derived neurotrophic factor protects against delayed neuronal death after transient forebrain ischemia in rats. Neuroscience 89:643-647
83. Henrich-Noack P, Prehn JH, Krieglstein J 1996 TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke 27:1609-1614